Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.036 | 0.5 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |